UPDATE on angiotensin II receptor blocker (ARB) recalls – FDA updates recalled valsartan-containing and losartan-containing medicine information - Drug Information Update

FDA has updated the list of valsartan medicines under recall to incorporate additional repackagers of Aurobindo’s valsartan-containing medicine. FDA has also updated the list of losartan medicines under recall to include repackagers of Torrent’s and Camber’s losartan-containing medicines.

The agency also updated the list of valsartan medicines not under recall accordingly.

For more information, please visit: FDA Updates on ARB Recalls.